A Double‐Blind Randomized Controlled Trial To Study the Efficacy of Topiramate in a Civilian Sample of PTSD
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SUMMARY: Objective: To evaluate the efficacy and tolerability of topiramate in patients with posttraumatic stress disorder (PTSD). Method: We conducted a 12‐week double‐blind, randomized, placebo‐controlled study comparing topiramate to placebo. Men and women aged 18–62 years with diagnosis of PTSD according to DSM‐IV were recruited from the outpatient clinic of the violence program of Federal University of São Paulo Hospital (Prove‐UNIFESP), São Paulo City, between April 2006 and December 2009. Subjects were assessed for the Clinician‐Administered Posttraumatic Stress Scale (CAPS), Clinical Global Impression, and Beck Depression Inventory (BDI). After 1‐week period of washout, 35 patients were randomized to either group. The primary outcome measure was the CAPS total score changes from baseline to the endpoint. Results: 82.35% of patients in the topiramate group exhibited improvements in PTSD symptoms. The efficacy analysis demonstrated that patients in the topiramate group exhibited significant improvements in reexperiencing symptoms: flashbacks, intrusive memories, and nightmares of the trauma (CAPS‐B; P= 0.04) and in avoidance/numbing symptoms associated with the trauma, social isolation, and emotional numbing (CAPS‐C; P= 0.0001). Furthermore, the experimental group demonstrated a significant difference in decrease in CAPS total score (topiramate −57.78; placebo −32.41; P= 0.0076). Mean topiramate dose was 102.94 mg/d. Topiramate was generally well tolerated. Conclusion: Topiramate was effective in improving reexperiencing and avoidance/numbing symptom clusters in patients with PTSD. This study supports the use of anticonvulsants for the improvement of symptoms of PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519
Research works printed but not linked: 27
- American Psychiatric Association, 1980, Diagnostic and statistical manual of mental disorders
- 10.1001/archpsyc.1995.03950240066012 · DOI · Paper page
- Stein DJ, 2006, Pharmacotherapy for posttraumatic stress disorder, Cochrane Database Syst Rev, 25, CD 002795
- American Psychiatric Association, 2004, Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder
- 10.1111/j.1749-6632.1997.tb48287.x · DOI
- 10.1111/j.1528-1157.2000.tb02163.x · DOI · Paper page
- 10.1016/0920-1211(95)00105-0 · DOI
- Berlant JL, 2003, Antiepileptic treatment of posttraumatic stress disorder, Prim Psychiatry, 10, 41
- 10.1080/07853890310017044 · DOI · Paper page
- 10.1016/0006-3223(93)90252-9 · DOI · Paper page
- 10.1016/S0079-6123(08)63163-5 · DOI · Paper page
- 10.4088/JCP.v64n0215f · DOI
- 10.1001/archpsyc.1992.01820080032005 · DOI · Paper page
- 10.1521/pedi.1995.9.2.83 · DOI · Paper page
- 10.1186/1471-244X-9-34 · DOI · Paper page
- 10.1002/jts.2490080106 · DOI · Paper page
- 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- Guy W., 1976, ECDEU assessment manual for psychopharmacology
- 10.1002/bimj.200310045 · doi:10.1002/bimj.200310045
- 10.4088/JCP.v63n0104 · DOI · Paper page
- 10.1186/1471-244X-4-24 · DOI · Paper page
- Akuchekian Sh, 2004, The comparison of topiramate and placebo in the treatment of posttraumatic stress disorder: A randomized, double‐blind study, J Res Med Sciences, 5, 240
- 10.4088/JCP.v68n0204 · DOI
- 10.1097/jcp.0b013e31815a43ee · DOI · Paper page
- 10.1097/JCP.0b013e31802e5115 · DOI · Paper page
- 10.1192/bjp.175.1.17 · DOI · Paper page
- Berlant JL, 2006, Topiramate as a therapy for chronic PTSD, Psychiatry, 3, 40
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Anticonvulsants: Data on topiramate are mixed, with one RCT finding significant benefits over placebo [1010], while the other did not [1009] (Level 1, conflicting).”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“, 2012) and the anticonvulsant topiramate; (Yeh et al., 2011).”
BackgroundPharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418
Lee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W. (2016) · Depression and Anxiety · doi:10.1002/da.22511 · Cited by 416
Hoskins, M. D., Bridges, J., Sinnerton, R., Nakamura, A., Underwood, J. F. G., Slater, A., Lee, M. R. D., Clarke, L., Lewis, C., Roberts, N. P., et al. (2021) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1802920 · Cited by 127
“04) Other drugs Topiramate Two studies (Tucker et al., 2007; Yeh et al., 2010), n = 69, SMD = −0.”
Background
Metadata
- Authors
- Yeh, M. S. L., Mari, J. J., Costa, M. C. P., Andreoli, S. B., Bressan, R. A., & Mello, M. F.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2010-09-23
- Volume
- 17
- Issue
- 5
- Pages
- 305-310
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1482129140
- Cited by
- 63
- References
- 1
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Double‐Blind Randomized Controlled Trial To Study the Efficacy of Topiramate in a Civilian Sample of PTSD. https://app.cochat.ai/papers/10.1111/j.1755-5949.2010.00188.x
- The paper
- Yeh, M. S. L., Mari, J. J., Costa, M. C. P., Andreoli, S. B., Bressan, R. A., & Mello, M. F. (2011). A Double‐Blind Randomized Controlled Trial To Study the Efficacy of Topiramate in a Civilian Sample of PTSD. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/j.1755-5949.2010.00188.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.